Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Free Cash Flow: 2011-2025

Historic Free Cash Flow for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to -$2.2 million.

  • Aytu Biopharma's Free Cash Flow rose 53.39% to -$618,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 48.55%. This contributed to the annual value of -$2.2 million for FY2025, which is 26.09% down from last year.
  • As of FY2025, Aytu Biopharma's Free Cash Flow stood at -$2.2 million, which was down 26.09% from -$1.7 million recorded in FY2024.
  • Over the past 5 years, Aytu Biopharma's Free Cash Flow peaked at -$1.7 million during FY2024, and registered a low of -$28.8 million during FY2022.
  • In the last 3 years, Aytu Biopharma's Free Cash Flow had a median value of -$2.2 million in 2025 and averaged -$3.0 million.
  • As far as peak fluctuations go, Aytu Biopharma's Free Cash Flow surged by 82.21% in 2023, and later fell by 26.09% in 2025.
  • Over the past 5 years, Aytu Biopharma's Free Cash Flow (Yearly) stood at -$28.3 million in 2021, then fell by 1.70% to -$28.8 million in 2022, then surged by 82.21% to -$5.1 million in 2023, then spiked by 66.52% to -$1.7 million in 2024, then declined by 26.09% to -$2.2 million in 2025.